alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 178
Editorial Note: Nomenclature changes to part 178 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 178.2550 4-Hydroxymethyl-2,6-di-*tert*-butylphenol. 4-Hydroxymethyl-2,6-di*-tert-*butyl-phenol may be safely used as an antioxidant in articles intended for use in contact with food, in accordance with the following prescribed conditions: ( a ) The additive has a solidification point of 140°-141 °C.
( b ) The concentration of the additive and any other permitted antioxidants in the finished food-contact article does not exceed a total of 0.5 milligram per square inch of food-contact surface.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-6781
ROBERT J. BARKLEY, SR., Plaintiff - Appellant, versus NICHOLAS J. HUN, Commissioner; GEORGE TRENT, Warden of West Virginia Penitentiary; DAVID FORMHART, Arts and Crafts Coordinator; LARRY FORDYCE, Correctional Officer 1 and Arts and Crafts Director; PEGGY RHINE, Safety Director, Defendants - Appellees.
Appeal from the United States District Court for the Northern District of West Virginia, at Elkins. Robert Earl Maxwell, District Judge. (CA-95-85-2) Submitted: September 20, 1996 Decided: October 2, 1996 Before NIEMEYER, HAMILTON, and MOTZ, Circuit Judges. Affirmed by unpublished per curiam opinion. Robert J. Barkley, Sr., Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant appeals the district court's order dismissing his 42 U.S.C. § 1983 (1994) complaint. The district court assessed a filing fee in accordance with Evans v. Croom , 650 F.2d 521 (4th Cir. 1981), cert. denied , 454 U.S. 1153 (1982), and dismissed the case without prejudice when Appellant failed to comply with the fee order. Finding no abuse of discretion, we affirm the district court's order. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Editorial Note on Part 177
Editorial Note: Nomenclature changes to part 177 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 177.1595 Polyetherimide resin. The polyetherimide resin identified in this section may be safely used as an article or component of an article intended for use in contact with food, subject to the provisions of this section. ( a ) *Identity.* For the purpose of this section, the polyetherimide resin is 1,3-isobenzofurandione, 5,5′[(1-methyl-ethylidene)bis(4,1-phenyleneoxy)] bis-polymer with 1,3-benzenediamine (CAS Reg. No. 61128-46-9), and is derived from the condensation reaction of *m*-phenylenediamine and bisphenol A-dianhydride.
( b ) *Optional adjuvants.* The basic polymer identified in paragraph (a) of this section may contain optional adjuvant substances required in the production of basic resins or finished food-contact articles. The optional adjuvant substances required in the production of the basic polymer may include substances permitted for such use by applicable regulations as set forth in part 174 of this chapter.
( c ) *Specifications and extractives limitations* — ( 1 ) *Specifications.* Polyetherimide resin identified in paragraph (a) of this section shall have an intrinsic viscosity in chloroform at 25 °C (77 °F) of not less than 0.35 deciliter per gram as determined by a method titled “Intrinsic Viscosity of ULTEM Polyetherimide Using Chloroform as the Solvent,” which is incorporated by reference. Copies are available from the Center for Food Safety and Applied Nutrition (HFS-200), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( 2 ) *Extractive limitations.* Extractive limitations are applicable to the basic polyetherimide resin in the form of molded discs of thickness 0.16 centimeter (0.063 inch). The resin discs when extracted with distilled water at 121 °C (250 °F) for 2 hours yield total nonvolatile extractives of not more than 12.3 micrograms per square centimeter.
[50 FR 31351, Aug. 2, 1985; 50 FR 35535, Sept. 3, 1985]
H. Res. 150 

In the House of Representatives, U. S., 

February 28, 2017. 

Resolved, That at any time after adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule XVIII, 

declare the House resolved into the Committee of the Whole 

House on the state of the Union for consideration of the bill 

(H.R. 998) to provide for the establishment of a process for 

the review of rules and sets of rules, and for other purposes. 

The first reading of the bill shall be dispensed with. All 

points of order against consideration of the bill are waived. 

General debate shall be confined to the bill and shall not exceed one hour equally divided and controlled by the chair and 

ranking minority member of the Committee on Oversight and 

Government Reform. After general debate the bill shall be 

considered for amendment under the five-minute rule. The 

bill shall be considered as read. All points of order against 

provisions in the bill are waived. No amendment to the bill 

shall be in order except those printed in the report of the 

Committee on Rules accompanying this resolution. Each such 

amendment may be offered only in the order printed in the 
2 

•HRES 150 EH 

report, may be offered only by a Member designated in the 

report, shall be considered as read, shall be debatable for the 

time specified in the report equally divided and controlled by 

the proponent and an opponent, shall not be subject to 

amendment, and shall not be subject to a demand for division 

of the question in the House or in the Committee of the 

Whole. All points of order against such amendments are 

waived. At the conclusion of consideration of the bill for 

amendment the Committee shall rise and report the bill to 

the House with such amendments as may have been adopted. 

The previous question shall be considered as ordered on the 

bill and amendments thereto to final passage without intervening motion except one motion to recommit with or without 

instructions. 

SEC. 2. Upon adoption of this resolution it shall be in 

order to consider in the House the joint resolution (H.J. Res. 

83) disapproving the rule submitted by the Department of 

Labor relating to ‘‘Clarification of Employer’s Continuing 

Obligation to Make and Maintain an Accurate Record of 

Each Recordable Injury and Illness’’. All points of order 

against consideration of the joint resolution are waived. The 

joint resolution shall be considered as read. All points of 

order against provisions in the joint resolution are waived. 

The previous question shall be considered as ordered on the 

joint resolution and on any amendment thereto to final pas-
3 

•HRES 150 EH 

sage without intervening motion except: (1) one hour of debate equally divided and controlled by the chair and ranking 

minority member of the Committee on Education and the 

Workforce; and (2) one motion to recommit. 

Attest: 

Clerk.
# L_2020273DE.01001601.xml

| 20.8.2020 | DE | Amtsblatt der Europäischen Union | L 273/16 |
| --- | --- | --- | --- |

20.8.2020

DE

Amtsblatt der Europäischen Union

L 273/16

---

Berichtigung des Beschlusses (EU) 2019/1348 der Europäischen Zentralbank vom 18. Juli 2019 zum Verfahren zur Anerkennung von nicht dem Euro-Währungsgebiet angehörenden Mitgliedstaaten als Berichtsmitgliedstaaten im Sinne der Verordnung (EU) 2016/867 über die Erhebung granularer Kreditdaten und Kreditrisikodaten (EZB/2019/20)

(
  Amtsblatt der Europäischen Union L 214 vom 16. August 2019
  )

| 1. | Auf Seite 9 in Fußnote 3 von Anhang I: |
| --- | --- |

1.

Auf Seite 9 in Fußnote 3 von Anhang I:

Anstatt:

„Verordnung (EU) 2017/2335 der Europäischen Zentralbank vom 23. November 2017 über die Erhebung granularer Kreditdaten und Kreditrisikodaten (EZB/2017/38) (ABl. L 333 vom 15.12.2017, S. 66).“

muss es heißen:

„Leitlinie (EU) 2017/2335 der Europäischen Zentralbank vom 23. November 2017 über die Erhebung granularer Kreditdaten und Kreditrisikodaten (EZB/2017/38) (ABl. L 333 vom 15.12.2017, S. 66).“

| 2. | Auf Seite 12 in Fußnote 9 von Anhang II: |
| --- | --- |

2.

Auf Seite 12 in Fußnote 9 von Anhang II:

Anstatt:

„Verordnung (EU) 2017/2335 der Europäischen Zentralbank vom 23. November 2017 über die Erhebung granularer Kreditdaten und Kreditrisikodaten (EZB/2017/38) (ABl. L 333 vom 15.12.2017, S. 66).“

muss es heißen:

„Leitlinie (EU) 2017/2335 der Europäischen Zentralbank vom 23. November 2017 über die Erhebung granularer Kreditdaten und Kreditrisikodaten (EZB/2017/38) (ABl. L 333 vom 15.12.2017, S. 66).“

---
§ 211.22 Responsibilities of quality control unit. ( a ) There shall be a quality control unit that shall have the responsibility and authority to approve or reject all components, drug product containers, closures, in-process materials, packaging material, labeling, and drug products, and the authority to review production records to assure that no errors have occurred or, if errors have occurred, that they have been fully investigated. The quality control unit shall be responsible for approving or rejecting drug products manufactured, processed, packed, or held under contract by another company.
( b ) Adequate laboratory facilities for the testing and approval (or rejection) of components, drug product containers, closures, packaging materials, in-process materials, and drug products shall be available to the quality control unit.
( c ) The quality control unit shall have the responsibility for approving or rejecting all procedures or specifications impacting on the identity, strength, quality, and purity of the drug product.
( d ) The responsibilities and procedures applicable to the quality control unit shall be in writing; such written procedures shall be followed.
**Exhibit 32**

 

**CERTIFICATION**

 

The certifications set forth below are herebysubmitted to the Securities and Exchange Commission pursuant to, and solely forthe purpose of complying with, Section 1350 of Chapter 63 of Title 18 of theUnited States Code in connection with the filing on the date hereof with theSecurities and Exchange Commission of the Quarterly Report on Form 10-Q of theCompany for the quarter ended September 30, 2003.

 

Each of the undersigned hereby certifiesin his capacity as an officer of Citizens Bancshares Corporation andsubsidiaries (the “Company”) that the Quarterly Report of the Company on Form10-Q for the period ended September 30, 2003 fully complies with therequirements of Section 13(a) of the Securities Exchange Act of 1934 and thatthe information contained in such report fairly presents, in all materialrespects, the financial condition of the Company at the end of such period andthe results of operations of the Company for such period.

 

**SIGNATURES**

 

In accordance with the requirements of the Exchange Act, the registrantcaused this report to be signed on its behalf by the undersigned, thereuntoduly authorized.

 

 

**CITIZENSBANCSHARES CORPORATION**

 

 
| Date:  | November 13, 2003 | By:    | /s/ James E. Young                                           |   |
|--------|-------------------|--------|--------------------------------------------------------------|--------|
|   |              |   | James E. Young                                               |
|   |              |   | President and Chief Executive Officer                        |
|   |              |   |                                                         |
| Date:  | November 13, 2003 | By:    | /s/ Willard C. Lewis                                         |   |
|   |              |   | Willard C. Lewis                                             |
|   |              |   | Senior Executive Vice President and  Chief Operating Officer |
|   |              |   |                                                         |
|   |              |   |                                                         |
| Date:  | November 13, 2003 | By:    | /s/ Samuel J. Cox                                            |   |
|   |              |   | Samuel J. Cox                                                |
|   |              |   | Senior Vice President and  Chief Financial Officer           |
|        |                   |        |                                                              |        |  |

 

----
[No. 15378-9-III.

Division Three.

December 16, 1997.]

#### The State of Washington, *Respondent,*v. Leopold D. Kairuz, *Appellant.*

Appeal from a judgment of the Superior Court for Franklin County, No. 95-1-50265-1, Dennis D. Yule, J., entered December 5, 1995. *Affirmed*by unpublished opinion per Brown, J., concurred in by Sweeney, C.J., and Schultheis, J.
**Exhibit 31 (a)**I, John Whetzell certify that:1. I have reviewed this quarterly report on Form 10-Q of Northland Cable Properties SevenLimited Partnership;2. Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading with respect to theperiod covered by this quarterly report;3. Based on my knowledge, the financial statements, and other financial information included inthis quarterly report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periods presentedin this quarterly report;4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and we have: a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this quarterly report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and  c) Disclosed in this report any change in the registrant’s internalcontrols over financial reporting that occurred during the registrant’s most recentfiscal quarter that has materially affected, or is reasonably likely to affect, theregistrant’s internal controls over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal controls over financial reporting, to the registrant’s auditors andboard of directors: a) All significant deficiencies and material weaknesses in the design oroperation of internal controls over financial reporting, which are reasonablylikely to adversely affect the registrant’s ability to record, process, summarizeand report financial information; and  b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal controls overfinancial reporting.**Date: 11-13-07**        /s/  JOHN S. WHETZELL   John S. Whetzell
Department of the Treasury

Internal Revenue Service

Publication 4262A (1-2004)

Catalog Number 37661Z

Identity Validation

Photo ID and Social Security

Card (s) or other identifying

documents for themselves,

their spouse, and dependents

must be provided to protect

our customers.

INCORRECT

FORM W-2

INCORRECT

FORM W-2

Do NOT Change Any

Information on Form W-2.

If the problem with the Form W-2 is

an invalid SSN used by the taxpayer:

■ A paper return must be filed.

■ The paper return should reflect the

valid SSN/ITIN for the taxpayer.

■ The Form W-2 with the erroneous

SSN must be attached to the

paper return.

If a problem is discovered with the taxpayer's SSN

on Form W-2, encourage the taxpayer to request

a corrected Form W-2 from the employer.

SIDN

SiteIdentification Number

VITA/TCE Volunteers

make every

tax return

count!

Ensure the correct

number is entered in

the Paid Preparer’s

section of the tax

return in the SSN or

PTIN field.

If filing electronically,

make sure that the

proper defaults are set.

Easy as
§ 145.181 Artificially sweetened canned pineapple. ( a ) Artificially sweetened canned pineapple is the food that conforms to the definition and standard of identity prescribed for canned pineapple by § 145.180(a), except that in lieu of a packing medium specified in § 145.180(a)(2), the packing medium used is water artificially sweetened with saccharin, sodium saccharin, or a combination of both. Such packing medium may be thickened with pectin.
( b ) ( 1 ) The specified name of the food is “artificially sweetened ______”, the blank being filled in with the name prescribed by § 145.180(a) for canned pineapple having the same optional pineapple ingredient.
( 2 ) The artificially sweetened food is subject to the requirements for label statement of ingredients used, as prescribed for canned pineapple by § 145.180(a). If the packing medium is thickened with pectin, the label shall bear the statement “thickened with pectin”.
[42 FR 14414, Mar. 15, 1977, as amended at 58 FR 2880, Jan. 6, 1993]
<PAGE>   1
                                                                      EXHIBIT 21
                                                                      ----------

                         SUBSIDIARIES OF THE REGISTRANT

                                                              Jurisdiction
          Subsidiaries (a)                                    of Incorporation
          ------------                                        ----------------

Victoria's Secret Stores, Inc. (b)                            Delaware
Victoria's Secret Catalogue, LLC (c)                          Delaware
Bath & Body Works, Inc. (d)                                   Delaware
Gryphon Development, Inc. (e)                                 Delaware
Intimate Brands Service Corporation (f)                       Delaware

(a)      The names of certain subsidiaries are omitted since such unnamed
         subsidiaries, considered in the aggregate as a single subsidiary, would
         not constitute a significant subsidiary as of January 30, 1999.

(b)      Victoria's Secret Stores, Inc. is a wholly-owned subsidiary of the
         registrant.

(c)      Victoria's Secret Catalogue, LLC is a wholly-owned subsidiary of
         Victoria's Secret Catalogue Holding LLC, a Delaware limited liability
         corporation and a wholly-owned subsidiary of the registrant.

(d)      Bath & Body Works, Inc. is a wholly-owned subsidiary of the registrant.

(e)      Gryphon Development, Inc. is a wholly-owned subsidiary of the Gryphon
         Holding Corporation, a Delaware corporation and a wholly-owned
         subsidiary of the registrant.

(f)      Intimate Brands Service Corporation is a wholly-owned subsidiary of the
         registrant.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM JASON
INCORPORATED CONSOLIDATED BALANCE SHEET AT SEPTEMBER 25, 1998, AND CONSOLIDATED
INCOME STATEMENT FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 25, 1998.  AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000813471
<NAME> JASON INCORPORATED
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-25-1998
<PERIOD-START>                             DEC-27-1997
<PERIOD-END>                               SEP-25-1998
<CASH>                                           28956
<SECURITIES>                                         0
<RECEIVABLES>                                    52800
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                      45717
<CURRENT-ASSETS>                                142613
<PP&E>                                          168512
<DEPRECIATION>                                   78295
<TOTAL-ASSETS>                                  305676
<CURRENT-LIABILITIES>                            93440
<BONDS>                                          68500<F2>
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         35544
<OTHER-SE>                                       83206
<TOTAL-LIABILITY-AND-EQUITY>                    305676
<SALES>                                         288208
<TOTAL-REVENUES>                                288208
<CGS>                                           224523
<TOTAL-COSTS>                                   224523
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                5099
<INCOME-PRETAX>                                  14984
<INCOME-TAX>                                      5845
<INCOME-CONTINUING>                               9139
<DISCONTINUED>                                    1278
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     10417
<EPS-PRIMARY>                                      .51<F3>
<EPS-DILUTED>                                      .49
<FN>
<F1>COMPANY PRESENTS RECEIVABLES ON A NET BASIS IN COMPLIANCE WITH ARTICLE 10
REGULATION S-X.
<F2>INCLUDES ALL NON-CURRENT PORTION OF DEBT OBLIGATIONS.
<F3>THE EPS UNDER THE EPS PRIMARY TAG REPRESENTS BASIC EARNINGS PER SHARE IN
ACCORDANCE WITH STATEMENT OF FINANCIAL ACCOUNTING STANDARD NO. 128 EARNINGS PER
SHARE.
</FN>
        

</TABLE>
Editorial Note on Part 189
Editorial Note: Nomenclature changes to part 189 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 70 FR 40880, July 15, 2005; and 70 FR 67651, Nov. 8, 2005.

§ 189.145 Dulcin. ( a ) Dulcin is the chemical 4-ethoxyphenylurea, C9H12N2O2. It is a synthetic chemical having a sweet taste about 250 times that of sucrose, is not found in natural products at levels detectable by the official methodology, and has been proposed for use as an artificial sweetener.
( b ) Food containing any added or detectable level of dulcin is deemed to be adulterated in violation of the act, based upon an order published in the Federal Register of January 19, 1950 (15 FR 321).
( c ) The analytical methods used for detecting dulcin in food are in sections 20.173-20.176 of the “Official Methods of Analysis of the Association of Official Analytical Chemists,” 13th Ed. (1980), which is incorporated by reference. Copies may be obtained from the AOAC INTERNATIONAL, 481 North Frederick Ave., suite 500, Gaithersburg, MD 20877, or may be examined at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
[42 FR 14659, Mar. 15, 1977, as amended at 49 FR 10114, Mar. 19, 1984; 54 FR 24899, June 12, 1989]